Icon

FOSAPREPITANT DIMEGLUMINE (nda210064)- (EQ 150MG BASE/VIAL)

FOSAPREPITANT DIMEGLUMINE TEVA PHARMS USA
EQ 150MG BASE/VIAL
No Yes
Expired Expired
None None
None No
Fosaprepitant for Injection is a substance P/neurokinin-1 (NK1) receptor antagonist, indicated in adults, in combination with other antiemetic agents, for the prevention of: • acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin. • delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC).
0 0 0
Total Other Developers 14
Drugs with Suitability No
EQ 150MG BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.